• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Race/ethnicity and socioeconomic status affect the assessment of lipoprotein(a) levels in clinical practice.种族/民族和社会经济地位会影响临床实践中脂蛋白(a)水平的评估。
J Clin Lipidol. 2024 Sep-Oct;18(5):e720-e728. doi: 10.1016/j.jacl.2024.07.003. Epub 2024 Jul 22.
2
Racial and ethnic disparities in fecundability: a North American preconception cohort study.生育力方面的种族和族裔差异:一项北美孕前队列研究。
Hum Reprod. 2025 Apr 17. doi: 10.1093/humrep/deaf067.
3
Factors Associated with Lipoprotein(a) Testing Among Multiethnic Individuals.多民族个体中与脂蛋白(a)检测相关的因素。
J Gen Intern Med. 2025 Mar;40(4):756-763. doi: 10.1007/s11606-024-09126-6. Epub 2024 Oct 25.
4
Intra-individual Variability in Lipoprotein(a) Levels: Findings from a Large Academic Health System Population.脂蛋白(a)水平的个体内变异性:来自大型学术医疗系统人群的研究结果。
Eur J Prev Cardiol. 2024 Oct 24. doi: 10.1093/eurjpc/zwae341.
5
Race/ethnicity and socioeconomic status affect the assessment of lipoprotein(a) levels in clinical practice.种族/民族和社会经济地位会影响临床实践中脂蛋白(a)水平的评估。
medRxiv. 2024 May 14:2024.05.14.24307362. doi: 10.1101/2024.05.14.24307362.
6
Traditional Risk Factors, Optimal Cardiovascular Health, and Elevated Lipoprotein(a).传统风险因素、最佳心血管健康状态与脂蛋白(a)升高
Eur J Prev Cardiol. 2024 Nov 28. doi: 10.1093/eurjpc/zwae382.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis.脂蛋白(a)与低密度脂蛋白胆固醇介导的心血管风险的独立性:一项基于参与者水平的荟萃分析。
Circulation. 2025 Jan 28;151(4):312-321. doi: 10.1161/CIRCULATIONAHA.124.069556. Epub 2024 Nov 4.
9
Racial and Ethnic Minorities Underrepresented in Pain Management Guidelines for Total Joint Arthroplasty: A Meta-analysis.在全膝关节置换术疼痛管理指南中代表性不足的少数族裔:一项荟萃分析。
Clin Orthop Relat Res. 2024 Sep 1;482(9):1698-1706. doi: 10.1097/CORR.0000000000003026. Epub 2024 Mar 18.
10
Impact of diabetes on risk of major adverse cardiovascular events associated with lipoprotein(a) levels in patients with established atherosclerotic cardiovascular disease.糖尿病对已确诊动脉粥样硬化性心血管疾病患者中与脂蛋白(a)水平相关的主要不良心血管事件风险的影响。
Eur J Prev Cardiol. 2025 Mar 11. doi: 10.1093/eurjpc/zwaf036.

引用本文的文献

1
Lipoprotein (a) in the Development and Progression of Diabetic Retinopathy: A Systematic Review and Meta-Analysis.脂蛋白(a)在糖尿病视网膜病变发生发展中的作用:一项系统评价和荟萃分析
Medicina (Kaunas). 2025 Jun 24;61(7):1137. doi: 10.3390/medicina61071137.
2
Lp(a): Global Public Health Concern: Emerging Knowledge and Therapeutic Approaches.脂蛋白(a):全球公共卫生关注点——新认知与治疗方法
Curr Cardiol Rep. 2025 Jun 25;27(1):104. doi: 10.1007/s11886-025-02255-2.

本文引用的文献

1
Association of Lipoprotein(a) Levels With Myocardial Infarction in Patients With Low-Attenuation Plaque.载脂蛋白(a)水平与低衰减斑块患者心肌梗死的相关性。
J Am Coll Cardiol. 2024 May 7;83(18):1743-1755. doi: 10.1016/j.jacc.2024.03.367.
2
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice.2019 年 NLA 科学声明中脂蛋白(a)在临床实践中应用的重点更新。
J Clin Lipidol. 2024 May-Jun;18(3):e308-e319. doi: 10.1016/j.jacl.2024.03.001. Epub 2024 Apr 1.
3
Lipoprotein(a): An important piece of the ASCVD risk factor puzzle across diverse populations.脂蛋白(a):不同人群中动脉粥样硬化性心血管疾病(ASCVD)风险因素拼图的重要一块。
Am Heart J Plus. 2023 Nov 24;38:100350. doi: 10.1016/j.ahjo.2023.100350. eCollection 2024 Feb.
4
Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations.脂蛋白(a)、C 反应蛋白与一级和二级预防人群的心血管风险。
JAMA Cardiol. 2024 Apr 1;9(4):385-391. doi: 10.1001/jamacardio.2023.5605.
5
Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States.美国大型学术医疗系统中的脂蛋白(a)检测趋势。
J Am Heart Assoc. 2023 Sep 19;12(18):e031255. doi: 10.1161/JAHA.123.031255. Epub 2023 Sep 13.
6
Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses.脂蛋白(a)检测的趋势和后果:横断面和纵向健康保险索赔数据库分析。
Atherosclerosis. 2023 Feb;367:24-33. doi: 10.1016/j.atherosclerosis.2023.01.014. Epub 2023 Jan 20.
7
Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA).低密度脂蛋白胆固醇和脂蛋白(a)与心血管风险的关系:动脉粥样硬化多民族研究(MESA)。
Atherosclerosis. 2022 Dec;363:102-108. doi: 10.1016/j.atherosclerosis.2022.10.004. Epub 2022 Oct 8.
8
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.脂蛋白(a)与动脉粥样硬化性心血管疾病及主动脉瓣狭窄:欧洲动脉粥样硬化学会共识声明。
Eur Heart J. 2022 Oct 14;43(39):3925-3946. doi: 10.1093/eurheartj/ehac361.
9
Social Determinants of Cardiovascular Disease.心血管疾病的社会决定因素。
Circ Res. 2022 Mar 4;130(5):782-799. doi: 10.1161/CIRCRESAHA.121.319811. Epub 2022 Mar 3.
10
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.脂蛋白(a):一种与遗传相关的、因果性的、普遍存在的动脉粥样硬化性心血管疾病风险因素:美国心脏协会的科学声明。
Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):e48-e60. doi: 10.1161/ATV.0000000000000147. Epub 2021 Oct 14.

种族/民族和社会经济地位会影响临床实践中脂蛋白(a)水平的评估。

Race/ethnicity and socioeconomic status affect the assessment of lipoprotein(a) levels in clinical practice.

机构信息

Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, United States (Drs Pavlyha and Reyes-Soffer).

Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, United States (Mr. Li).

出版信息

J Clin Lipidol. 2024 Sep-Oct;18(5):e720-e728. doi: 10.1016/j.jacl.2024.07.003. Epub 2024 Jul 22.

DOI:10.1016/j.jacl.2024.07.003
PMID:39289124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11606743/
Abstract

BACKGROUND AND OBJECTIVE

High lipoprotein(a) [Lp(a)] levels are a risk factor for atherosclerotic cardiovascular disease (ASCVD), however Lp(a) ordering in clinical practice is low. This study examines how race/ethnicity and socioeconomic status influence Lp(a) ordering.

METHODS

This is a single center, retrospective study (2/1/2020-6/30/2023) using electronic medical records of adults with at least one personal ICD-10 diagnosis of ASCVD, aortic valve stenosis, resistant hypercholesterolemia (low-density lipoprotein cholesterol >160 mg/dL on statin therapy), and family history of ASCVD or high Lp(a). We evaluated Lp(a) level differences among racial/ethnic groups and sexes. We also assessed associations between diagnosis type, diagnosis number, age at diagnosis, race/ethnicity, socioeconomic score (based on zip codes), public health coverage and the presence of Lp(a) orders.

RESULTS

4% of our cohort (N=2,249 in 56,833) had an Lp(a) order (17.3% of whom identified as Hispanic, 8.7% non-Hispanic Black, 47.5% non-Hispanic White, and 27% Asian/other). Non-Hispanic Black and Hispanic patients had lower rates of Lp(a) orders (0.17% and 0.28%, respectively) when compared to non-Hispanic White patients (2.35%), p < 0.001, however, their median Lp(a) levels were higher, p < 0.001. Individuals on Medicaid or belonging to deprived socioeconomic groups were less likely to have an Lp(a) order (incidence rate ratio [IRR] = 0.40, p < 0.001 and IRR = 0.39, p < 0.001 respectively). Certain diagnosis (carotid stenosis, family history of ASCVD and familial hypercholesterolemia) and multiple diagnoses (>2) resulted in more Lp(a) orders compared to only one diagnosis (p < 0.001).

CONCLUSIONS

Lp(a) ordering is low in patients with or at risk for ASCVD. Non-Hispanic Black and Hispanic patients are less likely to have an Lp(a) order. Individuals on Medicaid and residing in socioeconomically deprived neighborhoods are less likely to have an Lp(a) order. Lp(a) orders depend on the type and number of patients' diagnoses.

摘要

背景与目的

高脂蛋白(a)[Lp(a)]水平是动脉粥样硬化性心血管疾病(ASCVD)的危险因素,但临床实践中 Lp(a)的检测率较低。本研究旨在探讨种族/民族和社会经济地位如何影响 Lp(a)的检测。

方法

这是一项单中心回顾性研究(2020 年 2 月 1 日至 2023 年 6 月 30 日),使用至少有一个 ASCVD、主动脉瓣狭窄、难治性高胆固醇血症(他汀类药物治疗后低密度脂蛋白胆固醇>160mg/dL)或 ASCVD 家族史或高 Lp(a)个人 ICD-10 诊断的成年人的电子病历。我们评估了不同种族/民族和性别人群之间的 Lp(a)水平差异。我们还评估了诊断类型、诊断数量、诊断时年龄、种族/民族、社会经济评分(基于邮政编码)、公共卫生覆盖范围以及 Lp(a)检测之间的关联。

结果

我们队列的 4%(N=2249 人,共 56833 人)有 Lp(a)检测(其中 17.3%为西班牙裔,8.7%为非西班牙裔黑人,47.5%为非西班牙裔白人,27%为亚洲/其他族裔)。与非西班牙裔白人患者(2.35%)相比,非西班牙裔黑人和西班牙裔患者的 Lp(a)检测率较低(分别为 0.17%和 0.28%),p<0.001,但他们的 Lp(a)水平中位数较高,p<0.001。接受医疗补助或属于贫困社会经济群体的个体不太可能进行 Lp(a)检测(发病率比 [IRR] = 0.40,p<0.001 和 IRR = 0.39,p<0.001)。与只有一个诊断(颈动脉狭窄、ASCVD 家族史和家族性高胆固醇血症)相比,多个诊断(>2 个)会导致更多的 Lp(a)检测(p<0.001)。

结论

ASCVD 患者或有 ASCVD 风险的患者的 Lp(a)检测率较低。非西班牙裔黑人和西班牙裔患者不太可能进行 Lp(a)检测。接受医疗补助的个体和居住在社会经济贫困社区的个体不太可能进行 Lp(a)检测。Lp(a)检测取决于患者诊断的类型和数量。